Skip to content
About Us
Services & Solutions
News & Resources
Catalog Product
Careers
Contact Us
Start a project

Perspective

Oligonucleotide Drug Discovery

This two-part webinar series explores recent developments in oligonucleotide chemistry, biology, DMPK, toxicological assessment, manufacture, and formulation.

Mar 8, 202464 words

Resources

  • 2024-03-08

This two-part webinar series explores recent developments in oligonucleotide chemistry, biology, DMPK, toxicological assessment, manufacture, and formulation.

Part1: Oligonucleotide Drug Discovery

  • Examine the synthesis and modification of oligonucleotides
  • Explore methods for determining pharmacokinetic parameters
  • Hear about state of the art discovery strategies

Keep reading

Related

PerspectiveSep 2, 2025

Lower PMI in Peptide Synthesis: Achievable, Measurable, and Scalable

Process mass intensity (PMI) is one of the most important metrics in sustainable manufacturing. It measures the total mass of raw materials required to produce a given mass of product. In…

Read
Case StudyJul 23, 2025

Case Study: Enable an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months

As GLP-1 receptor agonists continue to redefine treatment for metabolic diseases, drug developers are racing to bring new and more complex therapies to the clinic. But innovation alone is…

Read
PerspectiveJul 10, 2025

Process Development and Large-scale Manufacturing of the Key Northern Fragment of Enlicitide Decanoate

A new publication by MSD in Organic Process Research & Development details the process development and large-scale manufacturing of the key Northern Fragment of Enlicitide Decanoate.

Read

How can we help?

Our TIDES drug experts stand ready.

Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.

Small molecule projects? WuXi STA